Literature DB >> 29862551

Identifying signals of interest when screening for drug-outcome associations in health care data.

Anton Pottegård1, Jesper Hallas1, Shirley V Wang2, Joshua J Gagne2.   

Abstract

Mesh：

Year:  2018        PMID： 29862551      PMCID： PMC6089829          DOI： 10.1111/bcp.13634

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  17 in total

1.  THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?

Authors:  A B HILL
Journal:  Proc R Soc Med       Date:  1965-05

2.  The case-crossover design: a method for studying transient effects on the risk of acute events.

Authors:  M Maclure
Journal:  Am J Epidemiol       Date:  1991-01-15       Impact factor: 4.897

Review 3.  Use of self-controlled designs in pharmacoepidemiology.

Authors:  J Hallas; A Pottegård
Journal:  J Intern Med       Date:  2014-06       Impact factor: 8.989

4.  Reuse of data sources to evaluate drug safety signals: When is it appropriate?

Authors:  Shirley V Wang; Martin Kulldorff; Robert J Glynn; Joshua J Gagne; Anton Pottegård; Kenneth J Rothman; Sebastian Schneeweiss; Alexander M Walker
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-04-27       Impact factor: 2.890

5.  Hydrochlorothiazide use is strongly associated with risk of lip cancer.

Authors:  A Pottegård; J Hallas; M Olesen; M T Svendsen; L A Habel; G D Friedman; S Friis
Journal:  J Intern Med       Date:  2017-06-06       Impact factor: 8.989

6.  Meningococcal conjugate vaccine safety surveillance in the Vaccine Safety Datalink using a tree-temporal scan data mining method.

Authors:  Rongxia Li; Eric Weintraub; Michael M McNeil; Martin Kulldorff; Edwin M Lewis; Jennifer Nelson; Stanley Xu; Lei Qian; Nicola P Klein; Frank Destefano
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-15       Impact factor: 2.890

7.  Evaluation of optic neuritis following human papillomavirus vaccination.

Authors:  Gayathri Sridhar; Fang Tian; Richard Forshee; Martin Kulldorff; Nandini Selvam; Andrea Sutherland; Wilson Bryan; Samuel Barone; Lei Xu; Hector S Izurieta
Journal:  Hum Vaccin Immunother       Date:  2017-05-02       Impact factor: 3.452

8.  Hydrochlorothiazide enhances UVA-induced DNA damage.

Authors:  Makoto Kunisada; Taro Masaki; Ryusuke Ono; Hironobu Morinaga; Eiji Nakano; Flandiana Yogianti; Kunihiro Okunishi; Hiroshi Sugiyama; Chikako Nishigori
Journal:  Photochem Photobiol       Date:  2013-02-25       Impact factor: 3.421

9.  Identification of Associations Between Prescribed Medications and Cancer: A Nationwide Screening Study.

Authors:  Anton Pottegård; Søren Friis; René dePont Christensen; Laurel A Habel; Joshua J Gagne; Jesper Hallas
Journal:  EBioMedicine       Date:  2016-03-14       Impact factor: 8.143

10.  New use of prescription drugs prior to a cancer diagnosis.

Authors:  Anton Pottegård; Jesper Hallas
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-11-27       Impact factor: 2.890
View more
  4 in total

1.  Spotlight-Introducing a new Commentary series for the BJCP.

Authors:  Andrew J Webb
Journal:  Br J Clin Pharmacol       Date:  2019-04-25       Impact factor: 4.335

2.  Spotlight Commentary: A post approval look at anticoagulants.

Authors:  Li Wei; Adam Cohen; Ton de Boer
Journal:  Br J Clin Pharmacol       Date:  2019-04-25       Impact factor: 4.335

3.  Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study.

Authors:  Bettina Kulle Andreassen; Nathalie C Støer; Jan Ivar Martinsen; Giske Ursin; Elisabete Weiderpass; G Hege Thoresen; Karen Boldingh Debernard; Øystein Karlstad; Anton Pottegard; Søren Friis
Journal:  BMJ Open       Date:  2019-04-08       Impact factor: 2.692

4.  A systematic assessment of the association between frequently prescribed medicines and the risk of common cancers: a series of nested case-control studies.

Authors:  R D McDowell; C Hughes; P Murchie; C Cardwell
Journal:  BMC Med       Date:  2021-01-26       Impact factor: 8.775
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.